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Cohort Study. We also replicated previously reported HDL-
C-related SNPs in a combined (discovery plus replication) 
sample (4,830 men and 5,540 women). We then analyzed the 
interactions of the HDL-C-related SNPs with PA on HDL-C. 
The sex-stratified GWA analyses identified 11 and 10 HDL-C-
related SNPs in men and women as targets for an interaction 
analysis. Among these, only one interaction of ABCA1 rs1883025 
with PA was statistically significant in men, after Bonferroni 
correction [P-interaction = 0.001 ( = 0.05/21 = 0.002)]. 
Abstract Few studies have investigated the interactions be-
tween HDL-C-related SNPs identified by genome-wide asso-
ciation (GWA) study and physical activity (PA) on HDL-C. 
First, we conducted a sex-stratified GWA study in a discovery 
sample (2,231 men and 2,431 women) and replication sam-
ple (2,599 men and 3,109 women) to identify SNPs influenc-
ing log-transformed HDL-C in Japanese participants in the 
baseline survey of the Japan Multi-Institutional Collaborative 
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The per-major-allele (C allele) increase in log-transformed 
HDL-C was lost in men with low PA ( = 0.008) compared 
with those with medium ( = 0.032) or high PA ( = 0.034).  
These findings suggest that the benefit of carrying a C allele 
of ABCA1 rs1883025 on enhancing HDL-C may be attenu-
ated in inactive men.—Nishida, Y., T. Hachiya, M. Hara, C. 
Shimanoe, K. Tanaka, Y. Sutoh, A. Shimizu, A. Hishida, M. 
Tsukamoto, Y. Kadomatsu, I. Oze, Y. N. Koyanagi, N. Kuriyama, 
T. Koyama, R. Ibusuki, T. Takezaki, H. Ikezaki, N. Furusyo, N. 
Takashima, A. Kadota, H. Uemura, S. Katsuura-Kamano, 
S. Suzuki, H. Nakagawa-Senda, K. Kuriki, H. Mikami, Y. 
Nakamura, Y. Momozawa, M. Kubo, M. Nakatochi, M. Naito, 
and K. Wakai. The interaction between ABCA1 polymor-
phism and physical activity on the HDL-cholesterol levels in 
a Japanese population, J. Lipid Res. 2020. 61: 86–94.
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adenosine 5′-triphosphate binding cassette transporter A1
Higher levels of circulating HDL-C have been consis-
tently associated with a reduced risk of cardiovascular dis-
ease (1). HDL, the lipoprotein carrying HDL-C, plays a 
major role in reverse cholesterol transport (RCT), wherein 
the cholesterol accumulated in macrophages in the artery 
vessel walls is extracted and transported to the liver and 
subsequently to the intestine for excretion from body 
(2, 3). Thus, increased HDL-C concentrations and en-
hanced RCT are generally considered to be important for 
preventing atherosclerosis and cardiovascular diseases.
The serum HDL-C levels are known to be strongly in-
fluenced by genetic factors (4). Previous genome-wide 
association (GWA) studies have identified at least 79 
SNPs that are associated with circulating HDL-C levels 
(4–6). However, the levels of serum HDL-C are also influ-
enced by other modifiable factors, such as physical activ-
ity (PA) (7), alcohol consumption (8), and cigarette 
habits (9). Habitual PA in particular is a low-cost non-
pharmacological measure that can increase the serum 
HDL-C concentration (7).
While there have been a few reports on the GWA meta-
analyses of HDL-C in populations predominantly of Euro-
pean ancestry (5) or East-Asian ancestry, in which Japanese 
individuals were partially included as a part of the total 
sample (6), there are few GWA studies of HDL-C in entirely 
Japanese populations. Ahmad et al. (10) showed that the 
effects of GWA analysis-derived HDL-C-related SNPs in 
genes involved in lipid metabolism [rs10096633 in LPL, 
rs1800588 in hepatic lipase (LIPC), and rs1532624 in cho-
lesteryl ester transfer protein (CETP)] on HDL-C were sig-
nificantly modified by habitual PA in women of European 
ancestry. However, gene-PA interactions are known to be 
influenced by subject characteristics, including sex and 
ethnicity (11). To date, there has been no GWA study that 
has investigated in both men and women the effects of in-
teraction between HDL-C-related SNPs (identified by GWA 
analysis) and PA on the HDL-C concentration in an under-
studied Japanese population.
Therefore, in the present study, we investigated the po-
tential interactions of the HDL-C-related SNPs derived 
from a GWA analysis and habitual PA on serum HDL-C lev-
els in Japanese men and women.
MATERIALS AND METHODS
Subjects
The study participants were middle-aged Japanese people 35–
69 years of age who voluntarily participated in the baseline survey 
of the Japan Multi-Institutional Collaborative Cohort (J-MICC) 
study on the gene-environment interactions of lifestyle-related 
diseases (12, 13). They were recruited from 12 different investiga-
tion areas (Chiba, Okazaki, Shizuoka-Daiko, Takashima, Kyoto, 
Sakuragaoka, Aichi, Saga, Kagoshima, Tokushima, Fukuoka, and 
Kyushu-KOPS) throughout Japan from 2004 to 2013 (the dataset 
version of January 11, 2018 was used in the present study). Infor-
mation on the variables of interest, including the subjects’ medi-
cal history, medications, and lifestyle factors (habitual PA, alcohol 
drinking, and cigarette smoking) were obtained via question-
naire, and blood samples were collected at the baseline survey.
A total of 14,555 subjects of J-MICC study were genotyped (by a 
method described below). Among these 14,555 subjects, 26 sam-
ples with inconsistent sex information between the questionnaire 
and an estimate from genotyping were excluded. The identity-by-
descent method implemented in the PLINK 1.9 software program 
(14) detected 388 close relationship pairs [pi-hat (an index of the 
degree of genetic similarity between two individuals) > 0.1875], and 
one sample of each pair was excluded. A principal component 
analysis (15, 16) with a 1000 Genomes reference panel (phase 3) 
(17) detected 34 subjects whose estimated ancestries were out-
side of the Japanese population (18), and these 34 subjects were 
also excluded. SNPs with a genotype call rate of <0.98 and/or a 
Hardy-Weinberg equilibrium exact test P-value < 1 × 106 were 
removed, leaving 14,091 individuals and 873,254 SNPs.
Of these 14,091 individuals who passed genotype quality con-
trol filtering, 2,435 were excluded because their HDL-C data (as 
outcome) were not available. In addition, another 1,100 subjects 
were excluded because they had a history of taking cholesterol-
lowering drugs. Consequently, 10,556 subjects remained.
To detect SNPs that are associated with serum HDL-C levels in 
the current GWA analysis, we restricted our sample to the 10,370 
individuals (4,830 men and 5,540 women) for whom we had data 
on all potential confounding factors, including the BMI, alcohol 
consumption, and cigarette habit (numbers of subjects missing 
data for the three covariates are described in the Statistical analy-
ses section). We used the data of 4,662 subjects (men, n = 2,231; 
women, n = 2,431) from the five investigation areas of Okazaki, 
Shizuoka-Daiko, Takashima, Kyoto, and Sakuragaoka for the dis-
covery stage, while the data of 5,708 subjects (men, n = 2,599; 
women, n = 3,109) from the other five areas of Fukuoka, Saga, 
Kagoshima, Tokushima, and Kyushu-KOPS were used for the rep-
lication stage.
Written informed consent was obtained from all participants, 
and the study protocol was approved by the Ethics Committees of 
the Nagoya University Graduate School of Medicine and other 
institutions participating in the J-MICC study. The study was con-
ducted in accordance with the Declaration of Helsinki principles.
Genotyping of polymorphisms and genotype imputation
The buffy coat fraction was collected from the blood samples 
(EDTA-2Na), and the extracted DNA was stored at 80°C. The 
genomic DNA was extracted from the buffy coat using a BioRobot 
M48 Workstation (QIAGEN Group, Tokyo, Japan) at the central 
J-MICC study office, except for the blood samples obtained from 
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two investigation areas (Fukuoka and Kyushu-KOPS). Regarding 
the blood samples obtained from those two areas, DNA was 
extracted locally (at the respective investigation sites) from whole 
blood using an automatic nucleic acid isolation system (NA-3000; 
Kurabo Co., Ltd., Osaka, Japan). Genotyping was performed 
at RIKEN Center for Integrative Medical Science using a Hu-
manOmniExpressExome BeadChip array (Illumina Inc., San 
Diego, CA), as previously described (19–21). Genotype imputa-
tion was conducted using the SHAPEIT (22) and Minimac3 (23) 
software programs based on the 1000 Genomes reference panel 
(phase 3) (17). After the genotype imputation, strict quality 
control filters were applied as previously described (24); namely, 
variants with an imputation R2 < 0.8 and a minor allele fre-
quency < 0.01 were excluded, resulting in 7,094,228 variants.
Heritability estimation
The narrow-sense heritability of the natural log-transformed 
HDL-C level was estimated based on the genotyping data using a 
mixed linear model (25) with adjustment for age, sex, and investi-
gation area. In brief, the model assumes that a genetic random 
effect for each individual is drawn from a multivariate normal dis-
tribution with mean 0 and a variance-covariance matrix calculated 
from genotype data [i.e., genetic relationship matrix (GRM)]. 
Similarly, a nongenetic random effect is assumed to be normally 
distributed with mean 0 and an identity variance-covariance ma-
trix. Adjustment variables were modeled as fixed-effect variables. 
The relative contribution of genetic and nongenetic effects was 
estimated using the restricted maximum likelihood method. To 
calculate the GRM, additional quality control filtering was ap-
plied according to a previous study (Hardy-Weinberg exact test 
P-value  0.05, and minor allele frequency  0.01) (7, 26), and 
the remaining 482,567 directly genotyped SNPs on autosomal 
chromosomes were used. Calculation of the GRM and heritability 
estimation were performed using the GCTA software program, 
version 1.24.2 (27).
Assessments of habitual PA, alcohol consumption, and 
cigarette habit by a questionnaire, and anthropometric 
measurements
Data on habitual PA, alcohol consumption, cigarette habit, cur-
rent medications, and disease history were collected using a self-
administered questionnaire. The total amount of habitual PA, 
which corresponds to an activity intensity of 3 metabolic equiva-
lents (METs), was assessed as previously described (28). Habitual 
PA was calculated as the sum of PA in daily life and leisure time. 
Each of the self-reported PA types was assigned to a specific MET 
value according to Compendium of Physical Activities (29), in 
which, for instance, walking (assumed to be 4.86 km/h) is as-
signed as 3.3 METs. The usual PA in daily life was estimated by 
multiplying the daily time spent for walking and engaged in physi-
cally heavy work by their assigned MET intensities (walking, 3.3 
METs; physically heavy work, 4.5 METs), while the leisure-time PA 
was estimated by multiplying the time spent per day by the as-
signed MET intensities for light activity (3.3 METs), moderate 
activity (4.0 METs), and vigorous activity (8.0 METs). One MET is 
defined as oxygen consumption of 3.5 ml/kg weight/min, which 
represents the average energy expenditure at rest.
Alcohol consumption was categorized as never, former, and 
current 0.1–22.9 g, 23.0–45.9 g, or 46 g ethanol/day [based on 
the fact that one glass of Japanese sake (180 ml) contains approxi-
mately 23 g ethanol]. The ethanol consumption per day was cal-
culated using data obtained via a validated short food frequency 
questionnaire (30–32).
Regarding the smoking habit, subjects were first asked about 
their smoking status from the past to the present. Current smokers 
were then requested to report their usual cigarette consumption 
(cigarettes/day). The smoking status was categorized as never, 
former, current 1–19, or current 20 cigarettes/day (based on 
the fact that one pack of cigarettes commonly contains 20 ciga-
rettes in Japan).
Anthropometric measurements and blood sampling were con-
ducted as part of the health checkup or for research purposes at 
the institutions participating in the J-MICC study (12). Height 
and weight were measured to the nearest 0.1 cm and 0.1 kg, re-
spectively. The BMI was determined by dividing the body weight 
in kilograms by the square of height in meters.
Measurement of serum HDL-C levels
Venous blood samples were drawn from each participant, and 
serum was separated by centrifugation and stored at 80°C until 
further use. The participants were not required to be in a fasting 
state. Nonfasting blood measures should not affect HDL-C levels 
(33). Serum HDL-C levels were measured via a polyanion-poly-
mer/detergent method. The HDL-C levels were examined as a 
part of the health checkup or for research purposes at the institu-
tions affiliated with the J-MICC study (34).
Statistical analyses
From the 10,556 subjects whose data remained (as men-
tioned above in the Subjects section), we further excluded 
those with any of the following conditions from the current 
GWA analysis stratified by sex: missing age data (n = 1), missing 
BMI data (n = 1), missing alcohol drinking data (n = 172), and 
missing cigarette smoking data (n = 12). Self-reported BMI data 
(calculated by self-reported weight and height) were used in 
place of objectively measured BMI data (calculated by mea-
sured weight and height) for subjects with missing objective 
BMI data (n = 232). Consequently, 10,370 individuals (men: n = 
4,830, women: n = 5,540) were ultimately included in the sex-
stratified GWA analysis.
The association between genetic variants and the natural log-
transformed HDL-C level was examined separately by sex using a 
mixed linear model association method (25) with adjustment for 
age (continuous), investigation site (categorical), BMI (continu-
ous), alcohol drinking (categorical), and cigarette smoking (cat-
egorical). Alcohol drinking status was coded as follows: never (0), 
former (1), current [2 (<23 g ethanol/day)], current [3 (23.0–
45.9 g ethanol/day)], or current [4 (46 g ethanol/day)]. The 
cigarette smoking status was coded as follows: never (0), former 
(1), current [2 (1–19 cigarettes/day)], or current [3 (20 ciga-
rettes/day)]. The same GRM used for heritability estimation was 
applied. Adjustment covariates and dosage data for each variant 
were modeled as fixed-effect variables, and genetic and nonge-
netic effects were modeled as random effect variables. The ge-
nome-wide significance level was set at a P-value of <5 × 108. 
Gene variants that achieved genome-wide significance in the dis-
covery stage were further investigated in the replication stage.
In addition, we conducted a replication in the Japanese popu-
lation using data of large-scale meta-analyses in populations pre-
dominantly of European ancestry (5) and in East Asian population 
including Japanese individuals (6). The former meta-analysis re-
ported 157 loci associated with lipid levels at P < 5 × 108, 71 of 
which were associated with HDL-C levels. The latter meta-analysis 
identified three variants in East Asian individuals and five variants 
in trans-ancestry analyses with European individuals (eight SNPs 
in total). Among these 79 variants, in the current J-MICC samples, 
10 variants showed low minor allele frequencies (<0.01), and 2 
showed a low imputation quality (<0.8). We therefore examined 
the association between the remaining 67 variants and the log-
transformed HDL-C levels in the current J-MICC samples (dis-
covery ± replication samples). Bonferroni’s corrected  for 
the replication was set at 0.00075 (0.05/67). SNPs identified 
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in the replication of previous studies were excluded from the tar-
get for the testing of interaction with PA, if they were in linkage 
disequilibrium (R2 > 0.9) (35) with the SNPs identified by the cur-
rent GWA analysis.
As the main part of the current statistical analysis, analyses of 
interactions between the HDL-C-related SNPs (identified by the 
current GWA study or identified by the replication of previous 
meta-analysis studies) and habitual PA on the serum HDL-C levels 
were performed separately by sex using the SAS software program 
(version 9.4 for Windows; SAS Institute, Cary, NC).
The significance of the univariate correlations between PA and 
the basic characteristics of the study subjects was assessed accord-
ing to Spearman’s rank correlation coefficient (). To examine 
the potential interaction of the HDL-C-related SNPs (identified by 
the GWA analysis) and habitual PA, an additional interaction term 
(each SNP × PA) (both SNP and PA were treated as continuous 
variables) was included in a multiple regression model with ad-
justment for the age (continuous), investigation site (categorical), 
BMI (continuous), alcohol drinking (categorical), and cigarette 
smoking (categorical). To avoid the false positive interactions due 
to multiple testing, Bonferroni’s corrected  was used for the inter-
action analysis (0.05/21 = 0.002) [number of target SNPs in men 
(n = 11) + women (n = 10) = 21]. An ANCOVA was used to calcu-
late the adjusted means of log-transformed serum HDL-C (and 
95% confidence interval) and to compare the adjusted geometric 
means of HDL-C among the three genotype groups in the three 
different PA groups divided into tertiles (low, medium, or high).
Replication of the interaction between HDL-C-related 
SNPs derived from the GWA analysis and habitual PA on 
HDL-C levels in another sample
Replication of the interaction was performed in subjects from 
the Saga region in the J-MICC study (4,013 men and 5,722 
women). Study participants from the Saga region who were in-
cluded in the original interaction analysis were completely ex-
cluded from the analysis for the replication of interaction. Similar 
exclusion criteria to the original analysis were applied to the repli-
cation. In these subjects, ABCA1 SNP rs1883025 was analyzed by a 
TaqMan® SNP genotyping assay using a StepOne Plus real-time 
PCR system (Applied Biosystems), and habitual PA was objectively 
measured by single-axis accelerometers (Life-corder; Suzuken Co. 
Ltd., Nagoya, Japan). PA level (PAL) was used as an index of ha-
bitual PA, as previously described in detail (36). Serum HDL-C 
levels and the four covariates (age, BMI, alcohol drinking, and 
cigarette smoking) were assessed in a manner similar to the origi-
nal interaction analysis. In the statistical model for the replication 
of interaction, the serum HDL-C levels were log-transformed, and 
the accelerometer wear time (minutes per day) was further added 
as a covariate in addition to the four above-mentioned covariates.
RESULTS
The sex-stratified GWA analysis of serum HDL-C levels in 
the Japanese population
The baseline characteristics of the current subjects in 
the discovery and replication samples are shown in supple-
mental Table S1. The narrow-sense heritability of the natu-
ral log-transformed HDL-C was estimated to be 30.3% (SE 
3.2%). We identified five and four SNPs influencing the 
HDL-C levels in men and women, respectively, at the ge-
nome-wide level of statistical significance (supplemental 
Table S2).
Replication of previous GWA studies
As a result of replication of previous GWA studies, seven 
variants in men and seven variants in women were signifi-
cantly associated with the serum HDL-C levels, after per-
forming Bonferroni’s correction [Bonferroni-corrected  = 
0.00075 (0.05/67 previously reported SNPs)] (supplemen-
tal Table S3). Among these identified SNPs, an SNP (CETP 
rs3764261) was excluded from the target SNPs for the test-
ing of interaction with PA because the CETP rs3764261 
was in strong linkage disequilibrium with CETP rs56156922 
(R2 = 0.92), which was identified in men and women by the 
sex-stratified GWA analysis.
Characteristics of the study subjects according to PA 
tertiles and correlations between PA and variables of 
characteristics
Characteristics of the study subjects analyzed for the in-
teraction between the HDL-C-related SNPs selected based 
on the GWA analysis and habitual PA are shown by three 
different PA levels (low, medium, and high) in Table 1. 
Higher PA was correlated with a higher age (in men and 
women), lower BMI (in men), higher alcohol drinking (in 
men), and higher HDL-C (in men and women). In con-
trast, the PA was not correlated with the total cholesterol in 
either men or women.
Interactions of the GWA analysis-derived SNPs and 
habitual PA on the serum HDL-C levels
As shown in Table 2, among the 11 HDL-C-related 
SNPs identified in men, only one significant interaction 
of ABCA1 SNP rs1883025 with habitual PA was detected, 
after Bonferroni’s correction [P-interaction = 0.0010 
(Bonferroni corrected  = 0.05/21 = 0.002)]. No such 
significant interaction of ABCA1 rs1883025 with PA was 
observed in women (Table 3). The other interactions 
examined in men and women did not reach statistical 
significance.
The genotype distribution of the ABCA1 rs1883025 in the 
Japanese population and correlations between the ABCA1 
SNP rs1883025 and characteristic variables of the subjects
The genotype distribution of the ABCA1 SNP rs1883025 
in the current subjects [men, TT: 8.0% (n = 385), CT: 
40.3% (n = 1,948), CC: 51.7% (n = 2,497); women, TT: 
8.5% (n = 469), CT: 40.7% (n = 2,254), CC: 50.8% (n = 
2,817) was confirmed to be very similar to the data for 
the Japanese general population (n = 172) reported in 
the public database for dbSNP (HapMap-JPT, TT: 8.1%, 
CT: 40.7%, CC: 51.2%). Correlations between the ABCA1 
SNP rs1883025 and characteristic variables are shown in 
Table 4. While the ABCA1 rs1883025 was not correlated 
with PA, it was significantly correlated with the serum 
HDL-C level in both men and women. It was confirmed 
that a higher number of C alleles (effect allele or major 
allele) of ABCA1 rs1883025 was associated with higher se-
rum HDL-C levels.
Stratified analyses according to different PA levels
As for the ABCA1 rs1883025, the adjusted geometric 
means (milligrams per deciliter) of HDL-C by three 
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genotypes (TT, CT, and CC) and regression coefficients 
() were analyzed according to the three different PA 
levels in men and women. The stratified analyses showed 
that the regression coefficients of the associations be-
tween the ABCA1 rs1883025 and natural log-transformed 
HDL-C were greater in men with medium PA [ = 0.032 
(SE 0.009)] or high PA [ = 0.034 (0.009)] than in men 
with low PA [ = 0.008 (0.009)] (Fig. 1A). In contrast, the 
regression coefficients of these associations of the ABCA1 
SNP and the log-transformed HDL-C were similar among 
the three different PA levels in women [low PA,  = 0.026 
(SE 0.008); medium PA,  = 0.036 (0.008); high PA,  = 
0.034 (0.008)] (Fig. 1B).
Replication of the interaction between ABCA1 SNP 
rs1883025 and PA on the serum HDL-C levels
Although the P value for the replication of interaction 
was marginal (P-interaction = 0.110), the stratified analyses 
(by three different PA levels) showed a similar pattern to 
the results obtained by the original interaction analysis in 
men, as the association between ABCA1 rs1883025 and log-
transformed HDL-C levels was most attenuated in physi-
cally inactive men ( = 0.021) compared with men with 
TABLE 1. Characteristics of the study subjects analyzed for the interaction between the SNPs selected based on the GWA analysis and  
habitual PA, according to PA tertiles
Characteristics
Men (n = 4,830) Women (n = 5,540)
Low PA  
(n = 1,581)
Medium PA  
(n = 1,642)
High PA  
(n = 1,607) a P
Low PA  
(n = 1,815)
Medium PA  
(n = 1,870)
High PA  
(n = 1,855) a P
Age (years) 54.1 (9.0) 54.9 (9.5) 55.0 (9.7) 0.047 0.001 53.2 (9.5) 53.9 (9.5) 54.4 (9.0) 0.049 0.0003
Height (cm) 168.2 (6.3) 167.6 (6.2) 166.6 (6.5) 0.105 <0.0001 155.1 (5.8) 155.0 (5.7) 154.3 (5.9) 0.063 <0.0001
Weight (kg) 67.9 (10.0) 67.1 (10.5) 65.8 (9.9) 0.098 <0.0001 54.2 (8.6) 53.0 (7.6) 53.6 (8.5) 0.031 0.019
BMI (kg/m2) 24.0 (3.1) 23.9 (3.3) 23.7 (3.1) 0.051 0.0004 22.6 (3.5) 22.1 (3.2) 22.5 (3.4) 0.002 0.867
Smoking status [n (%)] 0.004 0.785 0.016 0.222
 Never 417 (26.38) 464 (28.3) 439 (27.3) — — 1556 (85.7) 1635 (87.4) 1561 (84.2) — —
 Former 596 (37.7) 659 (40.1) 597 (37.2) — — 111 (6.1) 115 (6.2) 146 (7.9) — —
 Current
  1‒19 (cigarettes/day) 167 (10.56) 155 (9.4) 152 (9.5) — — 90 (5.0) 89 (4.8) 102 (5.5) — —
  20+ (cigarettes/day) 401 (25.36) 364 (22.2) 419 (26.1) — — 58 (3.2) 31 (1.7) 46 (2.5) — —
Alcohol consumption  
  [n (%)]
0.060 <0.0001 0.020 0.145
 Never 356 (22.52) 322 (19.6) 305 (19.0) — — 1164 (64.1) 1153 (61.7) 1144 (61.7) — —
 Former 48 (3.0) 44 (2.7) 41 (2.6) — — 33 (1.8) 31 (1.7) 29 (1.6) — —
 Current
  0.1‒22.9 (g/day) 554 (35.0) 617 (37.6) 518 (32.2) — — 526 (29.0) 596 (31.9) 592 (31.9) — —
  23.0‒45.9 (g/day) 294 (18.6) 323 (19.7) 327 (20.4) — — 63 (3.5) 71 (3.8) 63 (3.4) — —
  46.0+ (g/day) 329 (20.81) 336 (20.5) 416 (25.9) — — 29 (1.6) 19 (1.0) 27 (1.5) — —
PA (MET·h/day) 3.16 (1.54) 10.17 (2.58) 30.92 (13.37) 0.943 <0.0001 3.51 (1.97) 11.06 (2.72) 28.61 (12.34) 0.943 <0.0001
HDL-C (mg/dl)b 54.0 (1.3) 54.9 (1.3) 57.4 (1.3) 0.098 <0.0001 64.9 (1.3) 65.8 (1.3) 65.9 (1.3) 0.022 0.105
Total cholesterol (mg/dl)c 206.3 (32.8) 205.2 (32.4) 205.4 (33.3) 0.011 0.473 216.2 (37.3) 216.0 (35.2) 215.8 (35.0) 0.001 0.943
Values are mean (SD) for continuous variables and number (percentage) for categorical variables.
a Spearman’s rank correlation coefficient.
b Geometric mean (geometric SD).
c Based on 4,429 males and 5,091 females.
TABLE 2. P for interactions between the 11 HDL-C-related  
SNPs identified by the GWA analysis and habitual PA on the  
serum HDL-C levels in men
SNP Gene P-Interaction
Five SNPs identified by the current  
 GWA analysis
 rs651821 APOA5 0.318
 rs1077834 LIPC 0.169
 rs1800588a LIPC 0.184
 rs56156922 CETP 0.996
 rs2303790a CETP 0.691
Six SNPs identified by the replication  
 analysis of previously-reported SNPs
 rs12678919a LPL 0.721
 rs2293889a TRPS1 0.370
 rs1883025a ABCA1 0.0010
 rs964184a APOA1 0.470
 rs1532085a LIPC 0.520
 rs737337a ANGPTL8 0.735
ANGPTL8, angiopoietin-like 8; LIPG, endothelial lipase; TRPS1, 
transcriptional repressor GATA binding 1.
a Directly genotyped.
TABLE 3. P for interactions between the 10 HDL-C related SNPs 
identified by the GWA analysis and habitual PA on the serum HDL-C 
levels in women
SNP Gene P-Interaction
Four SNPs identified by the current  
 GWA analysis
 rs662799 APOA5 0.613
 rs1800588a LIPC 0.348
 rs56156922 CETP 0.311
 rs2303790a CETP 0.956
Six SNPs identified by the replication  
 analysis of previously-reported SNPs
 rs12678919a LPL 0.348
 rs1883025a ABCA1 0.796
 rs581080a TTC39B 0.672
 rs964184a APOA1 0.874
 rs838880a SCARB1 0.948
 rs1532085a LIPC 0.948
SCARB1, scavenger receptor class B member 1; TTC39B, tetratri-
copeptide repeat domain 39B.
a Directly genotyped.
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medium ( = 0.026) or high PA ( = 0.043) (Table 5). In 
contrast, the positive associations between rs1883025 SNP 
and HDL-C were similar among female subjects with differ-
ent PA levels (P-interaction = 0.638), which was also similar 
to the results obtained by the original interaction analysis 
in women (Table 5).
DISCUSSION
In the current study of a Japanese middle-aged popula-
tion, we found that the association of ABCA1 SNP rs1883025 
with the circulating HDL-C levels was modified by habitual 
PA levels in men, in which the beneficial association of car-
rying a C allele of ABCA1 SNP rs1883025 with elevated se-
rum HDL-C levels was masked in physically inactive men. 
The beneficial association of carrying a C allele with ele-
vated HDL-C levels may be mediated by daily PA in middle-
aged men. No such interaction of ABCA1 rs1883025 with 
PA (observed in men) was observed in women. In addition, 
replication of the interaction in another sample showed a 
similar result pattern in men, as the association between 
ABCA1 rs1883025 and objective habitual PA was most 
strongly attenuated in physically inactive men compared 
with men with medium or high PA, while no such interac-
tion was observed in women.
Several HDL-C-related SNPs identified in a large-scale 
meta-analysis in 188,577 individuals (5) or in 22,939 women 
of European ancestry (10) were not observed in the current 
GWA analyses. Additionally, among three HDL-C-related 
SNPs showing significant interaction with PA in women of 
European ancestry (10), one SNP (rs1800588 in LIPC) was 
also identified by the current sex-stratified GWA analyses, 
but its interaction with PA did not reach statistical signifi-
cance [P-interaction = 0.18 and 0.35 in men and women, 
respectively (Tables 2, 3)]. These differences from the previ-
ous largest-scale GWA studies may be partly explained by 
less statistical power due to the relatively small sample size 
of the current study, although our Japanese population was 
sufficiently large as a single ethnicity cohort. On the other 
hand, we found a novel interaction between ABCA1 
rs1883025 and PA that was not detected in the previous 
GWA study whose participants were only women (10). The 
previous GWA study of women might have missed the inter-
action, likely because it was a male-specific interaction.
The ABCA1 SNP rs1883025 is a well-known genetic fac-
tor that can modulate circulating HDL-C levels (4). ABCA1 
is an integral membrane protein that plays an important 
TABLE 4. Correlations between the characteristic variables and the 
ABCA1 SNP rs1883025, according to sex
Characteristics
Men (n = 4,830) Women (n = 5,540)

a P a P
Age (years) 0.019 0.178 0.039 0.003
Height (cm) 0.006 0.676 0.004 0.791
Weight (kg) 0.0005 0.973 0.005 0.733
BMI (kg/m2) 0.005 0.720 0.002 0.866
Smoking status [n (%)]b 0.015 0.300 0.025 0.064
Alcohol drinking [n (%)]c 0.007 0.616 0.036 0.008
PA (MET·h/day) 0.008 0.590 0.018 0.183
HDL-C (mg/dl) 0.056 <0.0001 0.096 <0.0001
The ABCA1 SNP rs1883025 was coded as 0 (TT), 1 (CT), or 2 (CC).
a Spearman’s rank correlation coefficient.
b Never, former, and current smoker of 1–19 or 20+ cigarettes per 
day.
c Never or former, and current drinker of 0.1–22.9, 23.0‒45.9, or 
46.0+ g ethanol per day.
Fig. 1. The associations between the ABCA1 SNP rs1883025 and 
serum HDL-C levels by the three different PA levels (low, medium, 
and high) in men (A) and women (B). Plots represent the adjusted 
means of the serum HDL-C levels and their 95% confidence 
intervals.
TABLE 5. Replication of the interaction between ABCA1 
polymorphism (rs1883025) and objectively measured PA on the  
serum HDL-C levels in subjects from the Saga region in the  
J-MICC study
PAL Tertiles a SE P-Trend P-Interaction
Men (n = 4,013) 0.110
 Low PAL (n = 1,336) 0.021 0.010 0.030 —
 Medium PAL (n = 1,334) 0.026 0.009 0.005 —
 High PAL (n = 1,343 0.043 0.009 <0.0001 —
Women (n = 5,722) 0.638
 Low PAL (n = 1,902) 0.028 0.008 0.000 —
 Medium PAL (n = 1,906) 0.024 0.007 0.001 —
 High PAL (n = 1,914) 0.033 0.007 <0.0001 —
a  indicates regression coefficients of associations between the 
ABCA1 rs1883025 [coded as 0 (TT), 1 (CT), 2 (CC)] and natural log-
transformed HDL-C.
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role in RCT (2). For instance, ABCA1 deficiency causes a 
rare disorder of Tangier disease that is associated with se-
verely impaired RCT and a markedly low level of serum 
HDL-C (37). Therefore, ABCA1 is considered to be a cen-
tral molecule for the biosynthesis of HDL-C (2, 37).
Previous studies have suggested the importance of 
ABCA1 gene induction in the mechanisms of the PA- 
induced increase in the serum HDL-C concentration. For 
instance, higher habitual PA was associated with a higher 
leukocyte ABCA1 mRNA expression, as well as a higher 
concentration of APOA-I and pre1-HDL [the first (or 
immature) particle in the HDL-C formation in the RCT] 
in Caucasian men (38). Consistently, rodent studies 
showed that endurance exercise enhanced the ABCA1 
gene expression in the liver and small intestine, which 
was accompanied by increased concentrations of APOA-I, 
pre1-HDL, and HDL-C (39–41). In addition, while it is 
known that pro-inflammatory interferon- suppresses the 
expression of the ABCA1 gene (42), our recent study sug-
gested that exercise-induced increases in HDL-C may be due 
in part to the reduction in the circulating interferon- con-
centration after exercise (43).
The magnitude of the association of HDL-C with PA dif-
fers among individuals. For example, in Japanese subjects, 
a low-intensity exercise regimen has been shown to be 
highly effective to increase serum HDL-C levels in older 
Japanese subjects (44), while a large inter-individual vari-
ability in the response of serum HDL-C to the same dura-
tion (per week) of low-intensity training was seen in this 
previous study. The current cross-sectional observational 
study indicates that the coincidence of two favorable fac-
tors (i.e., carrying the C allele of ABCA1 rs1883025 and 
active engagement with PA) may lead to higher serum 
HDL-C levels. Further exercise-intervention studies are 
needed to compare the extent of improvement in the 
serum HDL-C after longitudinal exercise training among 
Japanese men carrying different genotypes (TT, CT, CC) 
of the ABCA1 rs1883025.
To our knowledge, the functional molecular mecha-
nisms underlying how ABCA1 SNP rs1883025 (located in 
intron 2) modulates the serum HDL-C concentration are 
unknown at present, despite this SNP being well-known as 
an HDL-C-related SNP. The biological mechanisms under-
lying the interaction between the ABCA1 SNP rs1883025 
and habitual PA on HDL-C (that was observed only in 
men) is also currently unclear. Although the physiological 
and molecular genetic mechanisms by which the variants 
in the genes exert genotype-dependent differential effects 
on the improvement of lifestyle-related diseases through 
engagement with PA remain to be clarified (11), it is con-
ceivable that there are two patterns of results regarding the 
gene-PA interaction studies. One is that PA attenuates or 
counteracts the associations of the allele with health out-
comes (45, 46), while another is that PA amplifies or clari-
fies the associations of the allele with the outcomes (11). 
The current gene-PA interaction found in male subjects 
exhibits the second pattern, in which carrying the C allele 
of ABCA1 rs1883025 had only a negligible influence on the 
HDL-C level in inactive or sedentary men, whereas the 
beneficial association of carrying the C allele with an ele-
vated HDL-C level is manifested when carrying the C allele 
is accompanied by habitual engagement with PA.
The current findings prompted us to generate a hypoth-
esis regarding the molecular mechanism underlying the 
interaction of ABCA1 rs1883025 (located in intron 2) with 
PA. The expression of ABCA1 has been shown to be 
strongly regulated by nuclear LXR, which binds to the 
AGGTCA motif separated by four nucleotides in the ABCA1 
promoter region (47, 48), while the motif (AGGTCA) sep-
arated by zero to six nucleotides may potentially work as 
the nuclear LXR element (49). The importance of intra-
genic intron sequences for the regulation of ABCA1 expres-
sion has also been suggested (50). We then realized that 
the nucleotide sequence around the ABCA1 SNP rs1883025 
showed high homology [AGGTGT (CTA) AG G/A TCA] 
to the LXR biding site (G/A located at third nucleotide in 
the latter AGGTCA motif is rs1883025). Habitual PA (or 
exercise training) may upregulate the expression of LXR 
in white blood cells (51) and liver (52), as well as increase 
the oxysterol (natural ligand of LXR) levels in the arterial 
wall (53). We thus hypothesized that LXR protein activated 
by PA would bind more easily to the G allele [shown as C 
allele (complementary strand) in the current study] com-
pared with the A allele (shown as T allele in the present 
study). Consequently, men carrying the G allele might 
have increased ABCA1 gene expression as well as increased 
serum HDL-C levels. This hypothesis is more plausible than 
our initial one, considering that estrogen increases the ex-
pression of nuclear LXR (54), because the association of 
the C allele with increased HDL-C levels was clearly seen in 
inactive women, who are presumed to have higher estro-
gen levels than inactive men in the lowest PA tertile.
The strengths of the current study are the large sample 
size and careful adjustment for potential confounding fac-
tors, including the BMI, alcohol consumption, and smok-
ing habit in the interaction analysis. However, the present 
study also has several limitations. First, because this was a 
cross-sectional study, we were unable to make any causal 
inferences regarding the observed associations. Second, 
habitual PA was simply assessed by a self-administered ques-
tionnaire (not objective measurement) in the original in-
teraction analysis. Third, although the concept that HDL 
function, rather than HDL-C concentration, is important 
for the anti-atherogenic qualities of HDL has been pro-
posed (55–57), we did not measure the functional aspect 
of HDL and merely focused on the serum HDL-C levels in 
the current study. Finally, our subjects were limited to peo-
ple of Japanese ancestry, and the current results may not be 
generalizable to other ethnic groups.
In conclusion, the current results suggest that the asso-
ciation of ABCA1 SNP rs1883025 with serum HDL-C was 
significantly modified by habitual PA in Japanese middle-
aged men, with the beneficial association of carrying the C 
allele of ABCA1 rs1883025 being attenuated in inactive 
men compared with those with medium or high PA. It ap-
pears that middle-aged men carrying the C allele of ABCA1 
rs1883025 may enjoy benefits with regard to improved se-
rum HDL-C levels only when they are engaged in habitual 
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PA. In contrast, the association of carrying the C allele of 
the ABCA1 SNP with elevated serum HDL-C levels was simi-
lar or not markedly different among different PA levels in 
women. The current evidence will contribute to the devel-
opment of individualized PA programs to optimize the 
prevention and treatment of dyslipidemia or low HDL-C 
levels based on the individual genotypes of HDL-C-related 
SNPs.
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